Psychological stress affects response to sublingual immunotherapy in asthmatic children allergic to house dust mite

被引:18
作者
Ippoliti, Flora
de Santis, Wladimiro
Volterrani, Anna
Canitano, Nicoletta
Frattolillo, Daniele
Lucarelli, Sandra
Frediani, Simone
Frediani, Tullio
机构
[1] Univ Roma La Sapienza, Dept Paediat, Allergy & Immunol Div, I-00139 Rome, Italy
[2] Univ Roma La Sapienza, Dept Expt Med & Pathol, Rome, Italy
[3] Nuovo Regina Margherita Hosp, ASL RM A, Rome, Italy
关键词
adrenocorticotropic hormone; cortisol; ECP; prolactin; psychological stress; sublingual immunotherapy;
D O I
10.1111/j.1399-3038.2006.00417.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
While the clinical and immunologic efficacy of sublingual immunotherapy (SLIT) in allergic diseases has been extensively demonstrated, some patients display a poor clinical response. Psychological stress has been shown to play a role in atopy and also to affect response to immunomodulating therapies such as vaccination with microbial antigens. This study addresses the possibility of response to SLIT being affected by psychological stress. Forty children with mild asthma caused by allergy to Dermatophagoides pteronyssinus and farinae were subjected to SLIT and then divided after 6 months into two groups based on the results of the stress integrated measure (SIM) test: group 1 (24 stressed patients, mean SIM value of 60.1) and group 2 (16 non-stressed patients, mean SIM value of 7.6). There was also a higher prevalence of psychosocial stressing factors (divorced/absent parents, low income households, non-working parents) among stressed patients. The symptom score, peak expiratory flow (PEF), forced expiratory volume in 1 s (FEV1) and serum eosinophie cationic protein (ECP) concentration were evaluated at both times. The serum concentration of neuroendocrine parameters [prolactin, cortisol, adrenocorticotropic hormone (ACTH)] was also measured after 6 months of therapy. While all the clinical parameters and ECP concentration improved after SLIT, symptom score, PEF and ECP showed a significantly greater improvement in non-stressed patients. The concentration of neuroendocrine parameters was significantly increased in stressed patients. Our findings show that psychological stress can affect response to SLIT also in allergic subjects and are consistent with data recently reported showing a correlation between stress and poor response to antimicrobial vaccines. Our data also suggest that stress evaluation may become a useful prognostic factor in immunotherapy.
引用
收藏
页码:337 / 345
页数:9
相关论文
共 50 条
  • [21] Efficacy and safety of SQ house dust mite sublingual immunotherapy-tablet in Japanese children
    Masuyama, Keisuke
    Okamoto, Yoshitaka
    Okamiya, Kazuhiro
    Azuma, Ryuji
    Fujinami, Toshiaki
    Riis, Bente
    Ohashi-Doi, Katsuyo
    Natsui, Kensuke
    Imai, Toru
    Okubo, Kimihiro
    ALLERGY, 2018, 73 (12) : 2352 - 2363
  • [22] Efficacy, safety and immunological response with sq house dust mite sublingual immunotherapy-tablet by body weight in children
    Sato S.
    Hata H.
    Kobayashi S.
    Asaumi T.
    Yanagida N.
    Azuma R.
    Ohashi-Doi K.
    Ebisawa M.
    Denki Kagaku, 2020, 69 (09): : 918 - 927
  • [23] Sublingual immunotherapy may be effective in reducing house dust mite allergies in children with atopic dermatitis
    Kim, Minju
    Lee, Eun
    Yoon, Jisun
    Jung, Sungsu
    Song, Kun B.
    Choi, Eom J.
    Kim, Jeong-Hoon
    Yu, Jinho
    ACTA PAEDIATRICA, 2022, 111 (11) : 2142 - 2148
  • [24] Efficacy and safety of house dust mite subcutaneous immunotherapy in polysensitized children with allergic asthma
    Zhang, Panpan
    Jia, Yuanyuan
    Jing, Zenghui
    Huang, Jinli
    Wu, Huajie
    Sun, Xin
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2023, 78
  • [25] Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
    Ellis, Anne K.
    Gagnon, Remi
    Hammerby, Eva
    Lau, Andrea
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2019, 15 (1)
  • [26] Sublingual immunotherapy tablet for the treatment of house dust mite allergic rhinitis in Canada: an alternative to minimize treatment costs?
    Anne K. Ellis
    Rémi Gagnon
    Eva Hammerby
    Andrea Lau
    Allergy, Asthma & Clinical Immunology, 15
  • [27] Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures
    Pham-Thi, Nhan
    Scheinmann, Pierre
    Fadel, Riad
    Combebias, Anne
    Andre, Claude
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2007, 18 (01) : 47 - 57
  • [28] Dendritic cells modification during sublingual immunotherapy in children with allergic symptoms to house dust mites
    Angelini, Federica
    Pacciani, Valentina
    Corrente, Stefania
    Silenzi, Romina
    Di Pede, Alessandra
    Polito, Antonella
    Riccardi, Carla
    Di Cesare, Silvia
    Yammine, Marie Laure
    Rossi, Paolo
    Moschese, Viviana
    Chini, Loredana
    WORLD JOURNAL OF PEDIATRICS, 2011, 7 (01) : 24 - 30
  • [29] Efficacy and safety of sublingual immunotherapy using house dust mite tablet for 1-4 years old children with perennial allergic rhinitis
    Sasamoto, Koki
    Nagakura, Ken-ichi
    Asaumi, Tomoyuki
    Fusayasu, Naoko
    Ohashi-Doi, Katsuyo
    Yanagida, Noriyuki
    Sato, Sakura
    Ebisawa, Motohiro
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2024, 35 (07)
  • [30] 300 IR HDM tablet: a sublingual immunotherapy tablet for the treatment of house dust mite-associated allergic rhinitis
    Demoly, Pascal
    Okamoto, Yoshitaka
    Yang, William H.
    Devillier, Philippe
    Bergmann, Karl-Christian
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2016, 12 (11) : 1141 - 1151